Zhixu Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhixu Zhou has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Linwei Li
Jiangsu Key Laboratory for Conservation and Utilization of Plant Resources, Jiangsu Province Engineering Research Center of Eco‐Cultivation and High‐Value Utilization of Chinese Medicinal Materials Institute of Botany, Jiangsu Province and Chinese Academy of Sciences Nanjing 210014 China
2 shared publications - Changshan Sun
Pharmacy Department, Shenyang Pharmaceutical University, Shenyang 110016, PR China
1 shared publication - Chengjun Wu
Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, Ministry of Education, Shenyang 110016, P. R. China
1 shared publication Jian Huang
1 shared publication- Jinhui Wang
Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, Harbin Medical University, Harbin 150081, China
1 shared publication Ke Zhang
1 shared publication
Latest Publications
- 1 December 2016
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1125, 370-373
The stereochemistry of baishouwubenzophenone, a unique atropisomer from C. wilfordii
- 1 December 2016
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1125, 370-373
The stereochemistry of baishouwubenzophenone, a unique atropisomer from C. wilfordii
- Open Access
Synthesis, Crystal Structure, Absolute Configuration and Antitumor Activity of the Enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide
Pyridinesulfonamide is an important fragment which has a wide range of applications in novel drugs. R- and S-isomers of 5-bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide have been synthesized, and the stereostructures have been researched. Single crystals of both compounds were obtained for X-ray analysis, and the absolute configurations (ACs) have been further confirmed by electronic circular dichroism (ECD), optical rotation (OR) and quantum chemical calculations. The crystal structures and calculated geometries were extremely similar, which permitted a comparison of the relative reliabilities of ACs obtained by ECD analyses and theoretical simulation. In addition, the effect of stereochemistry on the PI3Kα kinase and anticancer activity were investigated. Compounds 10a and 10b inhibit the activity of PI3Kα kinase with IC50 values of 1.08 and 2.69 μM, respectively. Furthermore, molecular docking was performed to analyze the binding modes of R- and S-isomers.
Open AccessSynthesis, Crystal Structure, Absolute Configuration and Antitumor Activity of the Enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide
Pyridinesulfonamide is an important fragment which has a wide range of applications in novel drugs. R- and S-isomers of 5-bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide have been synthesized, and the stereostructures have been researched. Single crystals of both compounds were obtained for X-ray analysis, and the absolute configurations (ACs) have been further confirmed by electronic circular dichroism (ECD), optical rotation (OR) and quantum chemical calculations. The crystal structures and calculated geometries were extremely similar, which permitted a comparison of the relative reliabilities of ACs obtained by ECD analyses and theoretical simulation. In addition, the effect of stereochemistry on the PI3Kα kinase and anticancer activity were investigated. Compounds 10a and 10b inhibit the activity of PI3Kα kinase with IC50 values of 1.08 and 2.69 μM, respectively. Furthermore, molecular docking was performed to analyze the binding modes of R- and S-isomers.